Home / Blog / Defective medical products / Recall: 1 Lot Lamotrigine Oral Tablet due to Error in Packaging

Recall: 1 Lot Lamotrigine Oral Tablet due to Error in Packaging

Posted on September 10, 2016 1:54 pm under Defective medical products

On August 19, 2016, Impax Laboratories, Inc. (NASDAQ: IPXL) announced a nationwide recall for a lot of Lamotrigine Orally Disintegrating Tablet (ODT) because some 200 mg. labeled Unit-of-use blister packs may contain 100 mg product. The possibility of a reduced dosage can result in the return of symptoms.

Product Details: Lamotrigine ODT 200 mg tablets are off-white or white in color and circularly shaped at almost a centimeter and a half in diameter. “WPI” is imprinted on one side of the tablets and “3724” on the opposite side. The tablets come in blisters of 10, labeled NDC 0115-1529-15, or in cartons of 30, labeled NDC 0115-1529-08. The product was distributed to wholesalers and retail pharmacies across the US between June 13 and August 10 of this year.

Impax Laboratories, Inc. encourages customers to look closely at their stocks and notify Stericycle if they have an affected product.

When you purchase pharmaceuticals, you expect them to work properly and in cases where this doesn’t happen, you can end up feeling frustrated. Contact an attorney with Habush Habush & Rottier S.C. ® to start working toward potential compensation by calling (414) 271-0900 and setting up a free consultation.